Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one

被引：17

作者：

Velaparthi, Upender ^{[1
]}

Saulnier, Mark G. ^{[1
]}

Wittman, Mark D. ^{[1
]}

Liu, Peiying ^{[1
]}

Frennesson, David B. ^{[1
]}

Zimmermann, Kurt ^{[1
]}

Carboni, Joan M. ^{[4
]}

Gottardis, Marco ^{[4
]}

Li, Aixin ^{[4
]}

Greer, Ann ^{[4
]}

Clarke, Wendy ^{[2
]}

Yang, Zheng ^{[3
]}

Menard, Krista ^{[4
]}

Lee, Francis Y. ^{[4
]}

Trainor, George ^{[4
]}

Vyas, Dolatrai ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Dept Discovery Chem, Wallingford, CT 06492 USA

[2] Bristol Myers Squibb Co, Dept Metab & Pharmacokinet, Wallingford, CT 06492 USA

[3] Bristol Myers Squibb Co, Dept Metab & Pharmacokinet, Princeton, NJ 08543 USA

[4] Bristol Myers Squibb Co, Dept Oncol Drug Discovery, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 10期

关键词：

Insulin-like growth factor-1 receptor (IGF-1R); Kinases; IGF; Benzimidazole; Piperazine; CYP3A4; inhibition; Solubility; VIVO ANTITUMOR-ACTIVITY; DISCOVERY; BMS-536924;

D O I：

10.1016/j.bmcl.2010.03.057

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of 3-[6-(4-substitued-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one were synthesized to modulate CYP3A4 inhibition and improve aqueous solubility of our prototypical compound BMS-536924 (1), while maintaining potent IGF-1R inhibitory activity. Structure-activity and structure-solubility studies led to the identification of BMS-577098 (27), which demonstrates oral in vivo efficacy in animal models. The improvement was achieved by replacing morpholine with more polar bio-isoster piperazine and modulating the basicity of distal nitrogen with appropriate substitutions. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：3182 / 3185

页数：4

共 50 条

[1] Sar of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one inhibitors of the IGF-1 receptor kinase with in vivo antitumor activity.
Saulnier, MG
Velaparthi, U
Frennesson, DB
Liu, PY
Zimmermann, K
Sang, XP
Eummer, JT
Bedingfield, K
Lee, FY
Carboni, J
Vyas, DM
Haluska, P
Loegering, DA
Kaufmann, SH
Erlichman, C
Wittman, MD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U128 - U128
[2] MEDI 120-Influence of novel heterocyclic sidechains on the SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one inhibitors of the IGF-1R kinase
Frennesson, David B.
Saulnier, Mark G.
Struzynski, Charles
Langley, David
Velaparthi, Upender
Liu, Peiying
Zimmermann, Kurt
Sang, Xiaopeng
Lee, Francis Y.
Carboni, Joan
Li, Aixin
Greer, Ann
Balimane, Praveen
Yang, Zheng
Chang, Chiehying
Sack, John
Trainor, George L.
Wittman, Mark D.
Vyas, Dolatrai M.
Attar, Ricardo
Gottardis, Marco
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[3] MEDI 363-Discovery and SAR of a series of 3-[(6-piperidine-4-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-ones as IGF-1 receptor kinase inhibitors
Liu, Peiying
Velaparthi, Upender
Wittman, Mark D.
Saulnier, Mark G.
Zimmermann, K.
Sang, Xiaopeng
Frennesson, David B.
Lee, Francis Y.
Carboni, Joan
Greer, Ann
Li, Aixin
Attar, Ricardo
Gottardis, Marco
Yang, Zheng
Vyas, Dolatrai M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
[4] Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase
Wittman, Mark D.
Balasubramanian, Balu
Stoffan, Karen
Velaparthi, Upender
Liu, Pieying
Krishnanathan, Subramaniam
Carboni, Joan
Li, Aixin
Greer, Ann
Attar, Ricardo
Gottardis, Marco
Chang, Chiehying
Jacobson, Bruce
Sun, Yax
Hansel, Steven
Zoecklerf, Mary
Vyas, Dolatrai M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (04) : 974 - 977
[5] SAR of 3-(6-(piperidin-4-yl)-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of the insulin-like growth factor-1-receptor (IGF-1R) with broad spectrum in vivo activity
Velaparthi, Upender
Wittman, Mark D.
Liu, Peiying
Saulnier, Mark G.
Zimmermann, Kurt
Carboni, Joan
Lee, Francis Y.
Yang, Zheng
Frennesson, David B.
Sang, Xiaopeng
Li Aixin
Balimane, Praveen
Langley, David R.
Attar, Ricardo
Gottardis, Marco
Vyas, Dolatrai M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 764 - 764
[6] MEDI 240-SAR of 3-(6-(piperidin-4-yl)-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of the insulin-like growth factor-1-receptor (IGF-1R) with broad spectrum in vivo activity
Vartak, Ashish P.
Deaciuc, Agripina G.
Dwoskin, Linda P.
Crooks, Peter A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 880 - 880
[7] Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)
Velaparthi, Upender
Wittman, Mark
Liu, Peiying
Stoffan, Karen
Zimmermann, Kurt
Sang, Xiaopeng
Carboni, Joan
Li, Aixin
Attar, Ricardo
Gottardis, Marco
Greer, Ann
Chang, ChiehYing Y.
Jacobsen, Bruce L.
Sack, John S.
Sun, Yax
Langley, David R.
Balasubramanian, Balu
Vyas, Dolatrai
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (08) : 2317 - 2321
[8] MEDI 115-SAR of 3-(1H-Benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of IGF-1R Kinase: Balancing oral exposure and Cyp inhibition
Sang, Xiaopeng
Zimmermann, Kurt
Wittman, Mark D.
Saulnier, Mark G.
Velaparthi, Upender
Langley, David
Frennesson, David B.
Liu, Peiying
Carboni, Joan
Li, Aixin
Greer, Ann
Yang, Zheng
Balimane, Praveen
Vyas, Dolatrai M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[9] SAR of a series of 1H-and 3H-imidazo[4,5]pyridin-2-yl-pyridin-2(1H)-one and 9H-purin-8-yl-pyridin-2(1H)-one inhibitors of IGF-1R Kinase
Ouellet, Carl
Beaulieu, Francis
Wittman, Mark D.
Zimmermann, Kurt
Carboni, Joan
Lee, Francis Y.
Balimane, Praveen
Discenza, Lorell
Greer, Ann
Li, Aixin
Yang, Zheng
Banville, Jacques
Martel, Alain
Attar, Ricardo
Gottartis, Marco
Vyas, Dolatrai M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 759 - 759
[10] Discovery and optimization of imidazo[1,2-α]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R)
Emmitte, Kyle A.
Wilson, Brian J.
Baum, Erich W.
Emerson, Holly K.
Kuntz, Kevin W.
Nailor, Kristen E.
Salovich, James M.
Smith, Stephon C.
Cheung, Mui
Gerding, Roseanne M.
Stevens, Kirk L.
Uehling, David E.
Mook, Robert A., Jr.
Moorthy, Ganesh S.
Dickerson, Scott H.
Hassell, Anne M.
Leesnitzer, M. Anthony
Shewchuk, Lisa M.
Groy, Arthur
Rowand, Jason L.
Anderson, Kelly
Atkins, Charity L.
Yang, Jingsong
Sabbatini, Peter
Kumar, Rakesh
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 1004 - 1008

← 1 2 3 4 5 →